Unknown PHASE3 INTERVENTIONAL 2-arm NCT01168154

Role Of Lactobacillus Reuteri DSM 17938 In The Non-Complicated Diverticular Disease (ReDiCo)

Phase 3 Study of Lactobacillus Reuterii in Patients With Symptomatic Non-complicated Diverticular Disease

Sponsor: Careggi Hospital

Conditions Diverticulitis Diverticulosis

Interventions Lactobacillus Reuterii placebo

Updated 5 times since 2017 Last updated: Jun 27, 2011 Started: Feb 28, 2009 Primary completion: Dec 31, 2012 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01168154, this PHASE3 trial focuses on Diverticulitis and Diverticulosis and remains ongoing. Sponsored by Careggi Hospital, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Careggi Hospital
Casa Sollievo della Sofferenza IRCCS

Data source: Casa Sollievo della Sofferenza IRCCS

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Florence, Italy
• San Giovanni Rotondo, Italy